BBIO- Bridgebio Pharma, Inc.

Name: Bridgebio Pharma, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Bridgebio Pharma, Inc. (BBIO) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 18 sells. BBIO is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
?	Viking Global Investors LP	18.56M	$1.29B	-
10%	Bridgebio Pharma LLC	14.59M	$1.01B	-
CEO	Kumar Neil	4.40M	$305.96M	-
Dir	Homcy Charles J	916.7K	$63.76M	-
Dir	McCormick Frank	766.6K	$53.32M	-

Activity

Buys and sells only

Transactions

10 filings · page 11

Date	Insider	Role	Type	Shares	Price	Value	Chg%
Dec 15, 2020	Scheller Richard H90	See Remarks	Sale+OE	31,443	$60.38	$1,898,417.43	-9.7%
Dec 1, 2020	Henderson Michael Thomas58	Chief Business Officer	Sale+OE	10,000	$51.52	$515,204.08	-1.8%
Nov 25, 2020	Turtle Cameron	See Remarks	Sale+OE	5,000	$47.04	$235,180.84	-16.6%
Nov 16, 2020	Henderson Michael Thomas58	Chief Business Officer	Sale+OE	10,000	$45.00	$450,000.00	-3.6%
Nov 13, 2020	McCormick Frank61	Chairman Of Oncology	Sell	100,000	$42.76	$4,275,768.84	-2.6%
Nov 5, 2020	Turtle Cameron	See Remarks	Sale+OE	2,500	$42.05	$105,124.75	-16.6%
Nov 2, 2020	Henderson Michael Thomas58	Chief Business Officer	Sale+OE	10,000	$38.36	$383,557.65	-1.8%
Oct 16, 2020	Homcy Charles J	Chairman Of Pharmaceuticals	Sale+OE	10,256	$41.00	$420,496.00	-0.8%
Oct 1, 2020	Henderson Michael Thomas58	Chief Business Officer	Sale+OE	10,000	$38.83	$388,341.83	-1.8%
Sep 30, 2020	Turtle Cameron	See Remarks	Sale+OE	14,500	$37.69	$546,457.74	-34.8%

← PrevPage 11Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC